Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 10Carcinoma, Hepatocellular 9Neoplasm Metastasis 7Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Breast Neoplasms 3Glioblastoma 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Radiotherapy 1Prostate Cancer Metastatic 1Ovarian Neoplasms 1Neoplasm, Residual 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1

Interventions

Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Breast Cancer With Brain Metastasis × Radiosurgery × Clear all
NCT01924351 2020-03-18

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

University of Maryland, Baltimore

Phase 2 Withdrawn
Breast

Breast Cancer With Brain Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡